Skip to content

Cold Water and Decision-Making

Voluntary Cold-Water Immersion Effects on Value-Based Choice

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06908447
Acronym
CoVa
Enrollment
40
Registered
2025-04-03
Start date
2025-08-28
Completion date
2026-02-28
Last updated
2025-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior, Stress, Quality of Life, Psychological Wellbeing

Keywords

Decision-Making, Psychology, Stress, Cold-Exposure, Cold-Water Immersion

Brief summary

The behavioral within-subject cross-over design study CoVa aims to investigate the effect of a short-term full-body cold-water immersion vs. warm-water immersion control on value-based choice, psychological well-being, and peripheral physiology.

Detailed description

This randomized within-subject cross-over design behavioral study in cognitive neuroscience will employ an acute peripheral physiological intervention, i.e., a 10-minute full-body cold-water (10-16°C) immersion vs. a control condition (10 min @ 30- 36°C water) on two visits separated by approx. 30 days. Forty eligible female and male participants will be subject to a head-out full-body cold-water immersion or a warm-water condition (control) on two visits. Participants will perform resting-state and task-based non-invasive electrophysiological recordings of the heart, pulse, respiration, skin conductance, and pupil, will undergo thermographic imaging, pre- and post-immersion blood sampling (4 time points), engage in two computer-based decision-making tasks (reinforcement learning task, risk decision-making task), a brief food choice task, and receive a battery of psychometric questionnaires. The visits are separated by approximately 30 days and do not differ in their timeline except for the primary intervention, i.e., cold vs warm-water immersion, and the medical screening on visit 1.

Interventions

Single 10-minute acute full-body head-out single arm-out cold-water immersion at 10-16°C on the experimental day

BEHAVIORALWarm-water immersion (Control)

Single 10-minute acute full-body head-out single arm-out cold-water immersion at 30-36°C on the experimental day

Sponsors

German Institute of Human Nutrition
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-40 years of age * Consent to participate * Fluency in German * Physically and mentally healthy * BMI 18-30 kg/m2 * Normal day-night rhythm

Exclusion criteria

* Raynaud syndrome * Cold urticaria * High resting heart rate (\>160 beats per minute) * Acute infection * Diagnosed current or former illnesses of * Brain and mind * Heart and blood circulation * Gastrointestinal system * Endocrine system * Other serious past or present medical conditions * Wearing of medical devices (e.g., pacemaker) * Fear of blood, needles, or phlebotomy * Allergies to plasters, gels, and other medical equipment * Allergies to commercially available liquid meals (e.g., shakes, yfood Labs GmbH) * Recurrent intake of medication which affect metabolism * Regular nicotine consumption (e.g., vaping, cigarettes) * Excessive alcohol consumption (\>14 servings/week) * Recent illegal drug consumption (within 2 weeks prior) * Strong mental or physical stress * Excessive exercise (\>2 h high-intensity exercise/day) * Pregnancy or breastfeeding * Inability to wear skin-exposing swimwear, e.g., for religious reasons * Affinity for winter swimming, cryotherapy, breathwork (\>3 times/year)

Design outcomes

Primary

MeasureTime frameDescription
Positive affect and negative affect questionnaireOn day 1 and after 30 daysPsychological changes in affect, measured semi-continuously via the Positive Affect Negative Affect (PANAS) questionnaire to be filled out pre- and post-immersion. Measures for each item range from 1 (not at all) to 5 (very much) with 5 indicating the highest feeling perceived at the moment.
Identification of epigenetic markers associated with acute cold exposureOn day 1 and after 30 daysEpigenetic markers (micro-RNA) via blood sampling at 4 time points (pre-immersion to 120 min post-immersion)
Perceived controlOn day 1 and after 30 daysPsychological changes in perceived control, measured semi-continuously via self-reports throughout the experimental day. Measures range from 0% (not at all) to 100% (very much) with 100% indicating high perceived control.
Perceived freedomOn day 1 and after 30 daysPsychological changes in perceived freedom, measured semi-continuously via self-reports throughout the experimental day. Measures range from 0% (not at all) to 100% (very much) with 100% indicating high perceived freedom.
Perceived stressOn day 1 and after 30 daysPsychological changes in perceived stress, measured semi-continuously via self-reports throughout the experimental day. Measures range from 0% (not at all) to 100% (very much) with 100% indicating high perceived stress.
State of flowOn day 1 and after 30 daysPsychological changes in perceived state of flow, measured semi-continuously via self-reports throughout the experimental day. Measures range from 0% (not at all) to 100% (very much) with 100% indicating a high state of flow.
Self-efficacyOn day 1 and after 30 daysPsychological changes in self-efficacy, measured semi-continuously via self-reports throughout the experimental day. Measures range from 0% (not at all) to 100% (very much) with 100% indicating high self-efficacy.
Perceived painOn day 1 and after 30 daysPsychological changes in perceived pain, measured semi-continuously via self-reports throughout the experimental day. Measures range from 0% (not at all) to 100% (very much) with 100% indicating high perceived pain.
EmotionsOn day 1 and after 30 daysPsychological changes in emotions and their bodily origins, measured via self-reports pre- and post-immersion. Measures will be drawn on a virtual body using an adapted version of the Nummenmaa et al. (2014) emBODY tool with red color indicating increased perception and blue indicating decreased perception.
Pupil dilationOn day 1 and after 30 daysTask-based and resting-state pupil dilation, measured via eye-tracking
Risk propensityOn day 1 and after 30 daysRisk propensity, i.e., the ratio between risky and non-risky choices for each monetary value as measured in the risk decision-making task in the cold-water vs warm-water condition as described in Liu et al. (2021)
Behavioral range adaptationOn day 1 and after 30 daysParticipants will perform a computer-based reinforcement learning task described in Gueguen et al. (2024) to assess reward sensitivity in different monetary contexts. Behavioral range adaptation, which reflects value range-dependent, relative reward valuation, may be altered if reward processing itself is changed through a potent shift in the physiological state. To test whether reward processing is altered after cold vs warm water exposure, the extent to which range adaptation and reference-point centering occurs will be quantified using computational modeling methods.
Food choiceOn day 1 and after 30 daysParticipants will be provided an ad libitum restaurant-like breakfast meal during which they can order various food items (e.g., bread, yogurts, cookies) in the desired amount. The ingested food type, nutritional value, and amount will be quantified to assess food preference after cold vs warm water exposure by linking the consumed food with a standardized food database (German Nutrient Database, Bundeslebensmittelschlüssel).
Heart-rate variabilityOn day 1 and after 30 daysTask-based and resting-state heart-rate variability, measured with a three-point electrocardiogram (ECG)
Heart rateOn day 1 and after 30 daysTask-based and resting-state heart rate, measured with ECG
Respiration rateOn day 1 and after 30 daysTask-based and resting-state respiration rate, measured via a respiration belt
Relative amplitude of the respiratory signalOn day 1 and after 30 daysTask-based and resting-state relative respiratory amplitude, measured via a respiratory belt
Event-related skin conductance responsesOn day 1 and after 30 daysPhasic electrodermal activity, measured via electrodermal activity (EDA) electrodes
Tonic skin conductanceOn day 1 and after 30 daysTonic task-based and resting-state electrodermal activity, measured with EDA electrodes
Skin temperatureOn day 1 and after 30 daysThermographic imaging of the face, full-body, supraclavicular, and scapular area using a thermal camera pre-, during, and post-immersion
Plasma concentration of large neutral amino acidsOn day 1 and after 30 daysLarge neutral amino acid (LNAA) plasma concentration will be assessed via blood sampling at 4 time points (pre-immersion to 120 min post-immersion)
Plasma concentration of catecholaminesOn day 1 and after 30 daysCatecholamines via blood sampling at 4 time points (pre-immersion to 120 min post-immersion)
Plasma concentration of cortisolOn day 1 and after 30 daysCortisol via blood sampling at 4 time points (pre-immersion to 120 min post-immersion)

Secondary

MeasureTime frameDescription
Emotion regulation questionnaireOn day 1 and after 30 daysEmotion regulation, assessed via the Emotion Regulation Questionnaire (ERQ). Measures range from 1 (not at all true) to 7 (totally true) with 7 indicating the highest score.
Causality orientation questionnaireOn day 1 and after 30 daysCausality orientation, assessed via the General Causality Orientations Scale (GCOS). Measures range from 1 (very unlikely) to 6 (very likely) with 6 indicating the highest probability of responding as the item describes in the vignette scenario.
Delay discounting questionnaireOn day 1 and after 30 daysDelay discounting is assessed via the Delay Discounting Test by Kirby. Response options to each item are binary with one option corresponding to an immediate reward (e.g., 14 EUR today) and the second option corresponding to a higher but delayed reward (e.g., 19 EUR in 60 days).
Interoceptive awareness questionnaireOn day 1 and after 30 daysInteroceptive awareness, assessed via the Multidimensional Assessment of Interoceptive Awareness (MAIA) questionnaire. Measures range from 0 (never) to 5 (always) with 5 indicating the highest response.
Generalized self-efficacy questionnaireOn day 1 and after 30 daysGeneralized self-efficacy, assessed via the Self-Efficacy Scale (SWE). Measures range from not at all true, hardly true, moderately true and exactly true. A higher score, indicated by a preference for exactly true, indicated more self-efficacy.
Trait and state anxiety questionnaireOn day 1 and after 30 daysTrait and state anxiety, assessed via the State-Trait Anxiety Inventory (STAI-S and STAI-T). State anxiety is assessed on a scale from 1 (not at all) to 8 (very much) with a higher score indicating high state anxiety. Trait anxiety is assessed on a scale from 0 (almost never) to 3 (almost always) with a higher score indicating high trait anxiety.
Well-being questionnaireOn day 1 and after 30 daysPsychological well-being is assessed via the short version of the Warwick-Edinburgh Mental Well-Being Scale (SWEMWBS). Responses range from never to always on a 5-point scale with a high score indicating higher mental well-being in the past two weeks.
Trait autonomy questionnaireOn day 1 and after 30 daysTrait autonomy is assessed via the Basic Psychological Need Satisfaction and Frustration Scale (BPNSFS). Measures range from 1 (not at all true) to 5 (totally true) with 5 indicating the highest score.

Countries

Germany

Contacts

Primary ContactTrust Centre of the Human Study Centre Recruitment Officer
CoVa-Studie@dife.de+4933200 882753
Backup ContactMine Schmidt
mine.schmidt@dife.de+4933200 882518

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026